![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, February 03, 2023 4:01:18 AM
News of the deal falling apart is a particular blow to Regeneus, because it saw the deal as a validation of its technology, and it specifically chose the Japan market as its entry point because it believed it would quickly gain approval and be able to commercialize the product in other territories. Under the terms of the deal, Regeneus, of Sydney, was to receive $19 million in up-front and milestone payments, consisting of $9 million up front and $10 million in regulatory and development milestones. Regeneus would have also received double-digit royalties on sales and retained rights to negotiate licenses with other partners for additional indications inside and outside of Japan.
Check out Athersys' leadership page on the company's website which has been updated. The timing regarding of the announcement is positive. Dan has been AVOIDING any mention of a partnership until it is a done deal, something that could happen VERY soon. Get your ????? in order which they are inviting people to submit ??????????? .... GOOD LUCK LONGS
FEATURED BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • Jul 2, 2024 7:19 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM